{
    "@context": "https://schema.org",
    "@type": "Article",
    "headline": "Cornerstone Research Report Shows Continued Rate of Federal Securities Litigation Filings Targeting Pharmaceutical Industry",
    "url": "https://www.lexblog.com/2020/01/29/cornerstone-research-report-shows-continued-rate-of-federal-securities-litigation-filings-targeting-pharmaceutical-industry/",
    "identifier": {
        "@type": "PropertyValue",
        "name": "LexBlog Library record",
        "value": "LEX-WK-J5RKTN2F",
        "url": "https://www.lexblog.com/lib/J5RKTN2F/"
    },
    "datePublished": "2020-01-29T11:53:44-05:00",
    "dateModified": "2021-11-02T09:47:07-04:00",
    "author": {
        "@type": "Person",
        "name": "Gregg Weiner, Adam Harris, Life Sciences Litigation & Enforcement Team"
    },
    "sourceOrganization": {
        "@type": "Organization",
        "name": "Ropes & Gray"
    },
    "organizationScope": "at-publication",
    "isPartOf": "Life Sciences Securities Litigation",
    "about": "Banking, Finance and Securities",
    "sourceUrl": "http://lifescienceslitigation.ropesgrayblogs.com/?p=2021",
    "sourceStability": "may-move"
}